Statistical analysis of comparative data on composition and agronomic characteristics: new software tool and recurring issues identified

Similar documents
Bioinformatic analyses: methodology for allergen similarity search. Zoltán Divéki, Ana Gomes EFSA GMO Unit

Feedback from the Member States questionnaire

COMMISSION REGULATION (EU)

REPORT OF THE SPECIAL ADVISORY FORUM MEETING ON EU GMO RISK ASSESSMENT

Parma, 21/09/2015 SCIENTIFIC EVALUATION OF REGULATED PRODUCTS DEPARTMENT

Genotoxicity Testing Strategies: application of the EFSA SC opinion to different legal frameworks in the food and feed area

ADOPTED: x Month 201X PUBLISHED: dd mmmm yyyy AMENDED: dd mmmm yyyy doi: /j.efsa.20yy.nnnn

TECHNICAL REPORT OF EFSA

EFSA scientific advice to EC on new scientific information in relation to the risk assessment of genetically modified organisms

European Food Safety Authority (EFSA)

Using science to establish effective food safety control for the European Union Dr David Jukes

SCIENTIFIC OPINION. EFSA Panel on Genetically Modified Organisms (GMO) 2, 3

Guidance for risk assessment of food and feed from genetically modified plants 1. EFSA Panel on Genetically Modified Organisms (GMO) 2, 3

SCIENTIFIC OPINION. Abstract

EFSA Principles and Tools related to Risk Assessment of Food Enzymes

EFSA cross-cutting guidance lifecycle. European Food Safety Authority (EFSA), Daniela Maurici, Raquel Garcia Matas, Andrea Gervelmeyer

Guidance on the review, revision and development of EFSA s cross-cutting guidance documents

Scientific Opinion on modification of the terms of authorisation of VevoVitall (Benzoic acid) as a feed additive for weaned piglets 1

Welcome and introduction to EFSA

Dr. Allen Back. Oct. 7, 2016

REPORT OF EFSA. European Food Safety Authority 2. European Food Safety Authority (EFSA), Parma, Italy

GM plant environmental risk assessment: pros and cons of different approaches

Prof. Marina Heinonen University of Helsinki Member of the NDA Panel and EFSA s WG on Novel Foods

In this module I provide a few illustrations of options within lavaan for handling various situations.

Dr. Allen Back. Sep. 30, 2016

Action plan for improving the peer review process. European Food Safety Authority (EFSA)

RISK MANAGEMENT OPTION ANALYSIS CONCLUSION DOCUMENT

EFSA Info Session Pesticides 26/27 September Anja Friel EFSA Pesticides Unit (Residues team)

Theoretical Perspectives in the PhD thesis: How many? Dr. Terence Love We-B Centre School of Management Information Systems Edith Cowan University

Food Safety Risk Assessment and Risk Management at a European Level

Statement on the safety of MON810 maize pollen occurring in or as food 1

EFSA s Catalogue of support initiatives during the lifecycle of applications for regulated products

Preparatory work to support the re-evaluation of technological feed additives

1 OJ L 354, , p OJ L 80, , p. 19.

WORKABLE REGULATORY FRAMEWORK EUROPEAN PARLIAMENT, BRUSSELS 9 NOVEMBER 2016

Administrative guidance to applicants on the preparation and presentation of applications for authorisation of additives for use in animal nutrition

You argue that the Commission Decision is unlawful because of the following reasons:

EFSA Info Session on Applications. Technical meeting on food flavourings applications. Parma, 20 th January 2015

CRITERIA FOR USE. A GRAPHICAL EXPLANATION OF BI-VARIATE (2 VARIABLE) REGRESSION ANALYSISSys

GLP in the European Union Ecolabel detergents, GLP and accreditation

Module 14: Missing Data Concepts

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

Understandable Statistics

Investigator Initiated Study Proposal Form

Tocopherols (E ) used in foods for infants below 16 weeks of age

Practical guidance for applicants on the submission of applications on food additives, food enzymes and food flavourings

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2,3. European Food Safety Authority (EFSA), Parma, Italy

Clinical Quality Management Policy Clarification Notice

Preliminary Report on Simple Statistical Tests (t-tests and bivariate correlations)

EFSA PRE-SUBMISSION GUIDANCE FOR APPLICANTS INTENDING TO SUBMIT APPLICATIONS FOR AUTHORISATION OF HEALTH CLAIMS MADE ON FOODS

Evaluation & Reporting of Data: How to provide a (robust) study summary

Who are we? What are we doing? Why are we doing it?

Definition of Investigational Medicinal Products (IMPs) and use of Auxiliary Medicinal Products (AMPs)

SCIENTIFIC COMMITTEE. Minutes of the 11th meeting of the Working Group on Biological Relevance

Nutrition research and food legislation the role of EFSA

Evaluation of active substances in plant protection products Residues Anja Friel European Food Safetey Authority, Parma/ Italy

Software tool for calculating the predicted environmental concentrations (PEC) of plant protection products (PPP) in soil:

Estimation of animal intakes and HR, STMR and MRL calculations for products of animal origin

Bee guidance documents: An end users view. Mark Miles Research & Development Environmental Safety Ecotoxicology Bees

ANNEX 5 CONSUMER PRODUCT LABELLING BASED ON THE LIKELIHOOD OF INJURY

European public MRL assessment report (EPMAR)

Practical Statistical Reasoning in Clinical Trials

Draft Statement on Exposure Assessment of Food Enzymes

Overview of USP General Chapters <476> and <1086> Prescription/Non-Prescription Stakeholder Forum October 19, 2017

WWC STUDY REVIEW STANDARDS

Questions and Answers on Candidates for Substitution

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014

Guidance on the GLP Requirements for Peer Review of Histopathology Advisory Document

Prof. Rosangela Marchelli University of Parma WG on Novel Foods NDA Panel ( )

Linear Regression in SAS

PIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES

Toxicology and Allergology of GMO- Products Part 1

Bayesian approaches to handling missing data: Practical Exercises

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

Maintenance of weight loss and behaviour. dietary intervention: 1 year follow up

Risk Assessment to Risk Management Terminology of Risk Assessment. EFSA Project on Risk Assessment Terminology

Update ofefsa Guidanceon dermal absorption. A fewcase studies by a Member State

SCIENTIFIC OPINION. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) 2,3

Statement on the Safety Evaluation of Smoke Flavourings Primary Products: Interpretation of the Margin of Safety 1

We welcome the clarifications! Certain items may deserve further discussion

ECPA position paper on the criteria for the determination of endocrine disrupting properties under Regulation

Prof. Monika Neuhäuser-Berthold Justus Liebig Universität Giessen NDA Panel Member, Vice-Chair of WG Novel Foods, Chair of WG DRV for Vitamins

Safety assessment of GM food

COMMITTEE ON WORLD FOOD SECURITY

IRBES_R_04320 Generic drug name: Irbesartan + amlodipine Date: Study Code: 31 active centers: 20 in Korea, 7 in India and 4 in Philippines.

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

Emanuela Turla Scientific Officer Nutrition Unit - EFSA

CHECKLIST FOR EVALUATING A RESEARCH REPORT Provided by Dr. Blevins

Statement on the safety and efficacy of the product Rosemary extract liquid of natural origin as a technological feed additive for dogs and cats 1

CONSORT 2010 checklist of information to include when reporting a randomised trial*

SCIENTIFIC OPINION. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) 2,3

1.4 - Linear Regression and MS Excel

BIOL 458 BIOMETRY Lab 7 Multi-Factor ANOVA

Scientific Opinion on the modification to the formulation of GalliPro and compatibility with formic acid 1

First Phase of Impact Assessment on Endocrine Disruptors:

Overview Internal review

SCIENTIFIC OPINION. EFSA Panel on Genetically Modified Organisms (GMO Panel) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

BfR Proposal for a Harmonised Procedure for Estimating the Dermal Absorption

Challenges in environmental risk assessment (ERA) for birds and mammals and link to endocrine disruption (ED) Katharina Ott, BASF SE, Crop Protection

STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW Summary Record of Meeting of 25 June 2007

Transcription:

Statistical analysis of comparative data on composition and agronomic characteristics: new software tool and recurring issues identified C. Paoletti*, J. Perry and H. Broll* * EFSA GMO Unit; EFSA GMO Panel EFSA info session on applications - GMO Parma, Italy 28 October 2014

GMO software tool scope of the project Development of a software for the implementation of the EFSA Guidance for risk assessment of food and feed from GM plants (EFSA, 2011) Tool for stakeholders to comply with EFSA GMO guidelines Harmonization of statistical analyses for GMO dossiers Harmonization of reporting outcome of the analyses

GMO software tool input data

GMO software tool access to the software http://www.efsa.europa.eu/en/gmo/gmoanalysissoftware.htm

GMO software tool installation requirements

Main title Statistical evaluation of the field trials Contract with Hasselt University, Belgium Only field trial studies according to the latest EFSA Guidance, 2011 Dedicated time frame given for the evaluation (1 month) Two deliverables were requested from the contractor on each dossier: 1st deliverable: Evaluation report on the field trials highlighting issues for EFSA consideration (preparatory work) 2nd deliverable: Support the evaluation of the applicant s reply to EFSA questions

Main title Statistical evaluation of the field trials recurring issues Experimental design No information on randomization and blinding Requested in guidance but not always provided Exclusions Site exclusions: e.g. 10 included but only 8 analyzed: no proper explanation Sample exclusions: often not justified Can have implication on the minimum number of replicates

Main title Statistical evaluation of the field trials recurring issues Statistical analysis No statistical analysis plan (SAP) provided In line with good statistical practice Execution of R and SAS programs Re-analysis can not be carried out due to lack complete directory structure Values below Limit of Detection Substitution of ½ the detection limit Statistically, not the most appropriate way to handle non-detects, especially when frequency is medium high (e.g. around 30%)

Main title Statistical evaluation of the field trials recurring issues Statistical analysis Discrepancies found between the statistical outcome of the applicant and the re-analysis done by the Hasselt University Different outcome types identified No discussion of missing data mechanism (MCAR, MAR, MNAR) In line with good statistical practice When no equivalence limits can be established, often biological relevance is not discussed

Statistical evaluation of the field trials recurring issues Biological relevance example of an insufficient discussion All observed differences in this statistical analysis conducted under EFSA guidelines were characterized by a lack of compositional relevance from a food or feed perspective. This lack of relevance from a food or feed perspective is characterized by the small magnitudes of difference between the GM event (treated or not treated) and the control.

Main title Statistical evaluation of the field trials recurring issues Biological relevance expectations The applicant should report and discuss all significant differences observed between the GM plant, its comparator and, where applicable, any other test material, focusing on their biological relevance OECD listed endpoints are the basis. They serve as indicators for other parameters not measured but with safety relevance Consideration of the specific metabolic function/pathway

Main title Statistical evaluation of the field trials recurring issues Statistical analysis - Verification of assumptions Diagnostic Checks Assumption of normality of data and homogeneity of variance should always be checked Sometimes, only graphical can be subjective Some form of studentized/standardized residual used, but no proper justification is provided for the specific cut-off that is used When outliers found, analysis with and without outliers not always done Goodness-of-fit checks rarely done Linear mixed models have completely different theoretical implications on diagnostic checks than standard (fixed-effects) regression analysis. Conditional vs. marginal residuals Tests on normality, homogeneity of variance Box-Cox procedure

EFSA GMO Unit gmo@efsa.europa.eu Thank you for your attention! 13